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ABSTRACT 
Background: The human leukocyte antigen (HL4)-DQAI locus 
is only moderately polymorphic compared to other HLA class 
II loci; however, we hypothesized that these polymorphisms 
could be important in determining the humoral antibody 
response to measles vaccine virus. 
Methods: The seroprevalence of measles antibody was deter- 
mined in 881 school children who had been immunized with 
MMR-II at age approximately 15 months. All subjects resided 
in a geographic area with no circulating measles virus. The IgG 
antibody levels were determined by a measles-specific whole 
virus enzyme immunoassay (EIA) (BioWhittaker, Walkersville, 
MD). Subjects who were nonresponders (IgG seronegative or 
equivocal) (n = 46) and hyperresponders (upper 10th percentile 
of IgG levels of all subjects) (n = 64) were HLADQAI typed 
using polymerase chain reaction with sequence-specific primers 
(PCR-SSP). The HLA-DQAl allele frequencies, as well as 
homozygosity rates, were compared between the nonrespon- 
ders and hyperresponders. 
Results: The overall allele frequency distribution of alleles 
between the nonresponders and hyperresponders was sig- 
nificantly different (P = 0.05), with nonresponders having an 
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excess of HLA-DQAI *05 alleles (P = 0.017) and hyperrespon- 
ders having an excess of HLADQAI *Oi alleles (P = 0.016). The 
homozygosity rate among nonresponders was significantly 
higher than among hyperresponders (23.9% vs. 9.4%, P = 
0.037). 
Conclusion: HLA-DQAl alleles have important associations 
with the antibody response to measles vaccine. Specifically, 
the carriage of the HLA-DQAl*05 alleles is associated with 
nonresponse and that of HLA-DQAi*OI alleles with hyperre- 
sponse. In addition, HLADQAI homozygosity is significantly 
associated with poor antibody response to measles vaccine. 
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The human leukocyte antigen (HLA) loci exhibit a high 
degree of polymorphism. Numerous investigations have 
suggested an association between HLA alleles and sus- 
ceptibility to both autoimmune disorders and infectious 
diseases. Although the HLA-DQAl locus is only moder- 
ately polymorphic in comparison to other HLA loci,’ the 
presence of specific DQAl alleles has been associated 
with several diseases in several different ethnic popula- 
tions.2-6 Sollid and colleagues have suggested that spe- 
cific residues (69 and 75) may play a critical role in 
antigen binding and, therefore, may have a role in the 
specificity of antigens presented to T cells.* If indeed cer- 
tain alleles preferentially present specific antigens, the 
presence of these alleles may restrict the immunologic 
response to an infectious agent, such as live measles vac- 
cine virus. 
We have demonstrated previously that other HLA 
class I and II loci have strong associations with the cir- 
culating humoral antibody to measles vaccine virus7m9 
Homozygosity at the HIA-DRBl , TAP2 position 665, and 
HLA-B genes are associated with nonresponse to measles 
vaccine. In an effort to define the association between 
measles vaccine antibody levels and other class II HLA 
genes further, we examined the distribution of HLA-DQAl 
alleles and homozygosity rates between nonresponders 
and hyperresponders to measles vaccine. 
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METHODS 
The seroprevalence of measles antibody was determined 
in 881 healthy school children, ages 5 to 13 years, who had 
been immunized with MMR-II at approximately age 15 
months.’ All subjects resided in a geographic area with no 
circulating measles virus; therefore, the presence of mea- 
surable measles antibody could reasonably be attributed 
to immunization. Levels of IgG antibody were determined 
in duplicate, and the mean used, by a measles-specific 
whole virus enzyme immune assay (EL4) (BioWhittaker, 
Walkersville, MD). Subjects who were nonresponders 
(n = 46) (from the group who were IgG seronegative or 
equivocal) and hyperresponders (n = 64) (from the upper 
10th percentile of IgG levels of all subjects) were HLA- 
DQAl-typed by polymerase chain reaction (PCR) with 
sequence-specific primers (PCR-SSP) using published 
primerslo’ll and methods adapted for use in our laboratory. 
Briefly, genomic DNA was extracted from blood clots 
using a standard proteinase K digestion, followed by phe- 
nol/chloroform extraction and ethanol precipitation.l* 
Genomic DNA was amplified in 10 p,L reactions contain- 
ing 4 FM primers, 800 FM dNTPs, 0.4 units Taq poly- 
merase (Perkin-Elmer Cetus, Norwalk, CT), 5% glycerol 
(v/v), and 0.1 mg/mL cresol red. The PCR amplifications 
were carried out in a GeneAmp System 9600 (Perkin 
Elmer Cetus Instruments, Norwalk, CT), and the PCR prod- 
ucts were separated on a 1.5% agarose gel stained with 
ethidium bromide. 
When performing HLA-typing by PCR, homozygos- 
ity is assigned when only one allele is found. Subjects 
with only one allele could therefore be homozygous or 
carry an allele that our typing system is unable to detect, 
such as a new unreported allele. To overcome this limi- 
tation, we employed an internal positive amplification 
control. The absence of a sequence-specific product in 
the presence of a positive amplification-control product 
demonstrates that the PCR did work and the reaction can 
be considered negative. The absence of the internal pos- 
itive amplification product avoids mistakenly labelling a 
reaction negative when it was due to failure of the reac- 
tion. Secondly, we enrolled the birth parents of several of 
these subjects and HLA-DQAl typed them. From the alle- 
les carried by the parents, we are able to infer accurately 
whether the subjects are true homozygotes. 
The HLA-DQAl allele frequencies, as well as homozy- 
gosity rates, were compared between the nonresponders 
and hyperresponders using Pearson’s chi-square, and 
Fisher’s exact test when expected counts were small. A 
paired t-test was used for analysis of antibody levels. 
RESULTS 
The allele frequency distribution (each subject carries 
two alleles) between the measles vaccine nonresponders 
and hyperresponders was significantly different (p = 0.05, 
&i-square) (Figure 1). We then compared individual allele 
frequencies between nonresponders and hyperrespon- 
ders. Nonresponders had an excess of HLA-DQA1*05 
alleles (33.7%, n = 31 vs. 19.5%, n = 25, P = 0.017) and 
hyperresponders had an excess of HLA-DQAl*Ol alleles 
(50.0%, n = 64,vs. 33.7%, n = 31; P = 0.016). We also com- 
pared the homozygosity rates between the two groups. 
The homozygosity rate among nonresponders was sig- 
nificantly higher than among hyperresponders (23.9% 
[n = 111 vs. 9.4% [n = 61, P = 0.037, chi-square), and 
among the 17 homozygotes, the frequency of the differ- 
ent homozygote genotypes differed significantly between 
the nonresponders and hyperresponders (P = 0.01, Fig- 
ure 2). As the allele frequency data suggest, homozygous 
nonresponders were more likely to be HLA-DQA1*05 
(54.5%, n = 6) than any other homozygous genotype. In 
fact, no hyperresponders in this cohort were found to 
be HLA-DQAl*05 homozygous. We were able to confirm 
homozygosity in all subjects (n = 8) for whom we had 
family data available. 
The demographics of the measles vaccine nonre- 
sponders was similar to those of the measles vaccine 
hyperresponders. There was an equal gender distribution 
between the groups (nonresponders 48% female and 
hyperresponders 56% female, P = 0.46). Since all subjects 
were immunized at approximately 15 months of age, the 
age of the subject at enrollment can be used as an accu- 
rate proxy for time since immunization. To confirm that 
waning measles antibody levels over time were not 
responsible for the difference in antibody levels between 
the nonresponders and hyperresponders, the age range 
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Figure 1. The distribution of HLADQAI alleles between measles 
vaccine nonresponders and hyperresponders. The distribution of alle- 
les between the groups differed significantly (P = 0.05). Measles vac- 
cine nonresponders (#) were more likely to carry HL&DQA1*05 alleles, 
whereas hyperresponders (*) had more HLA-DQAl *Ol alleles. 
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Figure 2. Distribution of HLADQAl homozygotes between measles 
vaccine nonresponders and hyperresponders. Nonresponders were 
more likely to be HLADQAI *05 homozygotes (54.5%) than any other 
homozygous combination. Five of the six hyperresponder homozy- 
gotes were HLADQAI *Ol , whereas the other was an HLA-DQAI *03 
homozygote. 
of the nonresponders was 5 to 13 years (median, 9 years) 
and the age range of the hyperresponders was 5 to 12 
years (median, 8 years). Furthermore, we examined 
measles antibody levels from six hyperresponders. None 
of these subjects experienced a statistically or clinically 
significant decline in measles antibody titers over the 
approximately 3-year time frame. Similar data are not avail- 
able for nonresponders, because these subjects have been 
re-immunized. 
DISCUSSION 
In this study, HLA-DQAl alleles were found to be associ- 
ated with circulating humoral antibody to measles vaccine 
virus. Furthermore, the presence of specific alleles, HLA- 
DQAl*Ol, correlates with a vigorous antibody response 
to measles vaccine virus, whereas the presence of HLA- 
DQA1*05 alleles correlates with a poor antibody 
response. Other work has demonstrated similar associa- 
tions between specific class II HLA alleles and antibody 
response to vaccines. We previously reported that HLA- 
DRBl”l3 alleles are associated with strong antibody 
response to measles vaccine.13 An extended HLA haplo- 
type has been identified that is associated with failure to 
develop protective antibody levels after multiple doses of 
hepatitis B vaccine. l* 
Potentially more important is our fmding that HLA- 
DQAl homozygosity is significantly associated with non- 
response to measles vaccine and is consistent with our 
findings for three other HLA loci. We previously reported 
a significant association between seronegative humoral 
antibody levels after measles vaccination and HIA-DRBl 
homozygosity.7 Similarly, homozygotes of TAP2 amino 
acid position 665 and HLA-B homozygotes were more 
likely to be measles-vaccine nonresponders than were 
hyperresponders. These fmdings, together with this report 
of HLA-DQAl homozygosity, lend further support to the 
theory that allelic diversity and heterozygosity within the 
HLA system is advantageous for an optimal range of 
immune responses.15 
Although there is a l-year age difference between 
the hyperresponders and nonresponders, we do not 
believe this difference to be of importance. Evidence for 
this is that we previously reported that the average 
decline of measles antibody over time in this cohort was 
0.06 EL4 units per year. l6 Although this decline is mea- 
surable, it is not clinically significant and is not large 
enough to allow subjects to move from the hyper- 
responder group to the nonresponder group over the 
time frame represented by this study. 
Strong linkage disequilibrium exists among the genes 
of the HLA system. We used logistic regression to assess 
the independent effects of HLA-DRBl, TAP2 position 665 
and HLA-DQAl homozygosity on measles vaccine non- 
response and hyperresponse. The association of antibody 
levels with HLA-DQAl homozygosity was not significant 
(P = 0.16) with an odds ratio of 4.6 (95% confidence 
interval, CI: 0.55-38.81) adjusted for the effects of TAP2 
and DRBl homozygosity. Not surprisingly, the significance 
of the contribution of individual genes may diminish, but 
our power to rule out the effects of individual genes is 
very small; however, homozygosity at DRBl remains sta- 
tistically significant after adjusting for DQA and TAP2 
(odds ratio OR = 12.3, CI: 1.89-80.14, P = 0.009). With 
the data available thus far, we have inadequate power to 
address the impact of linkage disequilibrium on these 
findings. 
As stated in our hypothesis, we believe that there is 
likely a multigene influence over antibody response and 
we plan to examine extended HLA haplotypes. However, 
we recognize that this study design decreases our power 
to detect associations in this preliminary communica- 
tion, particularly for the purposes of addressing linkage 
disequilibrium. 
CONCLUSION 
HLA-DQAl alleles are associated with humor-al antibody 
levels to measles vaccine virus. The HLA-DQAl *0 1 alleles 
are associated with hyperresponse, whereas HLA- 
DQA1*05 alleles are associated with nonresponse to 
measles vaccine. Overall, and consistent with previous 
findings, HLA-DQAl homozygosity is significantly associ- 
ated with negative or poor antibody levels to measles 
vaccine virus. 
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